• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The placebo effect and its clinical associations in gambling disorder.赌博障碍中的安慰剂效应及其临床关联。
Ann Clin Psychiatry. 2017 Aug;29(3):167-172.
2
Placebo response in trichotillomania.拔毛癖中的安慰剂反应。
Int Clin Psychopharmacol. 2017 Nov;32(6):350-355. doi: 10.1097/YIC.0000000000000185.
3
Diverse predictors of treatment response to active medication and placebo in gambling disorder.赌博障碍患者对活性药物和安慰剂治疗反应的不同预测因素。
J Psychiatr Res. 2021 Dec;144:96-101. doi: 10.1016/j.jpsychires.2021.09.053. Epub 2021 Sep 30.
4
Does sustained-release lithium reduce impulsive gambling and affective instability versus placebo in pathological gamblers with bipolar spectrum disorders?与安慰剂相比,缓释锂能否减轻双相谱系障碍病理性赌博者的冲动性赌博及情感不稳定症状?
Am J Psychiatry. 2005 Jan;162(1):137-45. doi: 10.1176/appi.ajp.162.1.137.
5
Bupropion in the treatment of pathological gambling: a randomized, double-blind, placebo-controlled, flexible-dose study.安非他酮治疗病理性赌博:一项随机、双盲、安慰剂对照、灵活剂量研究。
J Clin Psychopharmacol. 2007 Apr;27(2):143-50. doi: 10.1097/01.jcp.0000264985.25109.25.
6
Pretreatment neurophysiological and clinical characteristics of placebo responders in treatment trials for major depression.重度抑郁症治疗试验中安慰剂反应者的预处理神经生理学和临床特征。
Psychopharmacology (Berl). 2004 Dec;177(1-2):15-22. doi: 10.1007/s00213-004-1919-2. Epub 2004 Jul 14.
7
Predicting placebo response in adolescents with major depressive disorder: The Adolescent Placebo Impact Composite Score (APICS).预测青少年重度抑郁症的安慰剂反应:青少年安慰剂影响综合评分(APICS)。
J Psychiatr Res. 2015 Sep;68:346-53. doi: 10.1016/j.jpsychires.2015.05.003. Epub 2015 May 15.
8
Multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling.纳美芬治疗病理性赌博的多中心研究。
Am J Psychiatry. 2006 Feb;163(2):303-12. doi: 10.1176/appi.ajp.163.2.303.
9
A double-blind, placebo-controlled trial of olanzapine for the treatment of video poker pathological gamblers.一项关于奥氮平治疗视频扑克病理性赌博者的双盲、安慰剂对照试验。
Pharmacol Biochem Behav. 2008 May;89(3):298-303. doi: 10.1016/j.pbb.2007.12.025. Epub 2008 Jan 7.
10
N-acetyl cysteine, a glutamate-modulating agent, in the treatment of pathological gambling: a pilot study.N-乙酰半胱氨酸,一种谷氨酸调节剂,用于治疗病态赌博:一项初步研究。
Biol Psychiatry. 2007 Sep 15;62(6):652-7. doi: 10.1016/j.biopsych.2006.11.021. Epub 2007 Apr 18.

引用本文的文献

1
Placebo effects in randomized trials of pharmacological and neurostimulation interventions for mental disorders: An umbrella review.精神障碍药物和神经刺激干预随机试验中的安慰剂效应:一项伞状综述。
Mol Psychiatry. 2024 Dec;29(12):3915-3925. doi: 10.1038/s41380-024-02638-x. Epub 2024 Jun 24.
2
Pharmacological Treatments for Disordered Gambling: A Meta-analysis.药物治疗赌博障碍:一项荟萃分析。
J Gambl Stud. 2019 Jun;35(2):415-445. doi: 10.1007/s10899-018-09815-y.

本文引用的文献

1
A Review of the Theoretical and Biological Understanding of the Nocebo and Placebo Phenomena.关于反安慰剂和安慰剂现象的理论与生物学理解的综述
Clin Ther. 2017 Mar;39(3):469-476. doi: 10.1016/j.clinthera.2017.01.010. Epub 2017 Feb 1.
2
Placebo: Unsolved Problems for Science, and Simple Conclusions for Clinical Practice.安慰剂:科学的未解之谜与临床实践的简单结论
Am J Psychiatry. 2017 Feb 1;174(2):91-92. doi: 10.1176/appi.ajp.2016.16101181.
3
Increasing placebo response in antipsychotic trials: a clinical perspective.抗精神病药物试验中安慰剂反应的增强:临床视角
Evid Based Ment Health. 2015 Aug;18(3):77-9. doi: 10.1136/eb-2015-102098. Epub 2015 Jun 29.
4
Genetics and the placebo effect: the placebome.遗传学与安慰剂效应:安慰剂组学
Trends Mol Med. 2015 May;21(5):285-94. doi: 10.1016/j.molmed.2015.02.009. Epub 2015 Apr 14.
5
Gambling disorder and its relationship with substance use disorders: implications for nosological revisions and treatment.赌博障碍及其与物质使用障碍的关系:对疾病分类修订和治疗的启示。
Am J Addict. 2015 Mar;24(2):126-131. doi: 10.1111/ajad.12112.
6
Placebo eff ects in psychiatry: mediators and moderators.精神病学中的安慰剂效应:中介因素与调节因素
Lancet Psychiatry. 2015 Mar;2(3):246-57. doi: 10.1016/S2215-0366(14)00092-3.
7
Placebo effects: from the neurobiological paradigm to translational implications.安慰剂效应:从神经生物学范式到转化意义。
Neuron. 2014 Nov 5;84(3):623-37. doi: 10.1016/j.neuron.2014.10.023.
8
Predictors of placebo response in bipolar depression.双相抑郁中安慰剂反应的预测因素。
Int Clin Psychopharmacol. 2015 Mar;30(2):59-66. doi: 10.1097/YIC.0000000000000058.
9
Obesity and gambling: neurocognitive and clinical associations.肥胖与赌博:神经认知及临床关联
Acta Psychiatr Scand. 2015 May;131(5):379-86. doi: 10.1111/acps.12353. Epub 2014 Oct 23.
10
A randomized, placebo-controlled trial of N-acetylcysteine plus imaginal desensitization for nicotine-dependent pathological gamblers.一项关于 N-乙酰半胱氨酸联合想象脱敏治疗尼古丁依赖病理性赌博者的随机、安慰剂对照试验。
J Clin Psychiatry. 2014 Jan;75(1):39-45. doi: 10.4088/JCP.13m08411.

赌博障碍中的安慰剂效应及其临床关联。

The placebo effect and its clinical associations in gambling disorder.

作者信息

Grant Jon E, Chamberlain Samuel R

机构信息

Department of Psychiatry and Behavioral Neuroscience, University of Chicago, Pritzker School of Medicine, Chicago, IL, USA E-mail:

出版信息

Ann Clin Psychiatry. 2017 Aug;29(3):167-172.

PMID:28738096
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5540171/
Abstract

BACKGROUND

Although gambling disorder is prevalent and functionally impairing, no FDA-approved medications exist for its treatment. The ability of clinical trials to detect the benefits of active treatment has been hindered by an unusually high placebo response. Virtually nothing is known about baseline clinical characteristics that might predict placebo response in those with gambling disorder.

METHODS

Participants (N = 152) assigned to placebo were pooled from multiple double-blind trials of gambling disorder. Participants were classified as placebo responders or non-responders based on a cut-off of 35% reduction in symptom severity on the Gambling Symptom Assessment Scale. Baseline group differences were characterized using t tests and equivalent non-parametric tests as appropriate.

RESULTS

Fifty-one percent of individuals assigned to placebo showed a significant clinical response. Compared with non-responders, placebo responders remained in treatment for significantly longer, were more likely to report "enjoyment" as a trigger for gambling, and were less likely to state that "boredom" or "loneliness" triggered their gambling. Placebo responders and non-responders did not differ significantly in age, sex, age at symptom onset, baseline symptom severity, comorbidities, or likelihood of having received a previous treatment.

CONCLUSIONS

Predictors of placebo response for gambling disorder appear markedly different from those reported for other mental illnesses.

摘要

背景

尽管赌博障碍很常见且会造成功能损害,但尚无美国食品药品监督管理局(FDA)批准用于治疗该疾病的药物。临床试验检测积极治疗益处的能力受到异常高的安慰剂反应的阻碍。对于可能预测赌博障碍患者安慰剂反应的基线临床特征,人们几乎一无所知。

方法

从多项赌博障碍双盲试验中汇总分配到安慰剂组的参与者(N = 152)。根据赌博症状评估量表上症状严重程度降低35%的临界值,将参与者分为安慰剂反应者或无反应者。使用t检验和适当的等效非参数检验来描述基线组间差异。

结果

分配到安慰剂组的个体中有51%显示出显著的临床反应。与无反应者相比,安慰剂反应者接受治疗的时间明显更长,更有可能报告“享受”是赌博的触发因素,而不太可能表示“无聊”或“孤独”是其赌博的触发因素。安慰剂反应者和无反应者在年龄、性别、症状发作年龄、基线症状严重程度、合并症或既往接受治疗的可能性方面没有显著差异。

结论

赌博障碍安慰剂反应的预测因素似乎与其他精神疾病所报告的预测因素明显不同。